Richard Capasso - 11 Nov 2021 Form 3 Insider Report for SQZ Biotechnologies Co

Role: Officer Title - Principal Accounting Officer and Chief Accounting Officer. Exhibit 24 - Power of Attorney
Signature: /s/ Lawrence Knopf, Attorney-in-fact for Richard Capasso
Issuer symbol: N/A
Transactions as of: 11 Nov 2021
Net transactions value: $0
Form type: 3
Filing time: 16 Nov 2021, 15:50:26 UTC
Next filing: 15 Feb 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	SQZB	Stock Option							11 Nov 2021	Common Stock	37,000	$15.18	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable as to 25% of the underlying shares on June 14, 2022 and in 36 equal monthly installments thereafter.

Remarks:

Officer Title - Principal Accounting Officer and Chief Accounting Officer. Exhibit 24 - Power of Attorney